login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
CASTLE BIOSCIENCES INC (CSTL) Stock News
USA
- NASDAQ:CSTL -
US14843C1053
-
Common Stock
23.08
USD
-0.58 (-2.45%)
Last: 10/10/2025, 9:19:19 PM
23.08
USD
0 (0%)
After Hours:
10/10/2025, 9:19:19 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
CSTL Latest News, Press Relases and Analysis
All
Press Releases
11 days ago - By: Castle Biosciences, Inc.
Castle Biosciences’ Founder, President and CEO Derek Maetzold Honored with the CEO of the Year Award by The CEO Magazine
11 days ago - By: Castle Biosciences, Inc.
Castle Biosciences’ Founder, President and CEO Derek Maetzold Honored with the CEO of the Year Award by The CEO Magazine
20 days ago - By: Castle Biosciences, Inc.
Castle Biosciences Honored with a Greater Pittsburgh Top Workplaces 2025 Award
20 days ago - By: Castle Biosciences, Inc.
Castle Biosciences Honored with a Greater Pittsburgh Top Workplaces 2025 Award
20 days ago - By: SciBase
SciBase receives initial order for clinical study from Castle Biosciences
2 months ago - By: The Motley Fool
Castle (CSTL) Q2 Revenue Tops Estimates
26 days ago - By: Castle Biosciences, Inc.
Castle Biosciences Named One of Newsweek’s America’s Greatest Companies 2025
26 days ago - By: Castle Biosciences, Inc.
Castle Biosciences Named One of Newsweek’s America’s Greatest Companies 2025
a month ago - By: Castle Biosciences, Inc.
New Data at American Foregut Society's 2025 Annual Meeting Demonstrates TissueCypher® Can Detect High-Risk Barrett’s Esophagus Patients Not Identified by Pathology to Support Improved Care Decisions
a month ago - By: Castle Biosciences, Inc.
New Data at American Foregut Society's 2025 Annual Meeting Demonstrates TissueCypher® Can Detect High-Risk Barrett’s Esophagus Patients Not Identified by Pathology to Support Improved Care Decisions
2 months ago - By: Benzinga
Examining the Future: Castle Biosciences's Earnings Outlook
2 months ago - By: Castle Biosciences, Inc.
New Evidence Published Supporting Use of DecisionDx®-SCC Test in Guiding and Improving Treatment Pathway Decisions in NCCN High-Risk Cutaneous Squamous Cell Carcinoma
2 months ago - By: Castle Biosciences, Inc.
New Evidence Published Supporting Use of DecisionDx®-SCC Test in Guiding and Improving Treatment Pathway Decisions in NCCN High-Risk Cutaneous Squamous Cell Carcinoma
2 months ago - By: Zacks Investment Research
- Mentions:
SIGI
CRSP
New Strong Sell Stocks for August 1st
2 months ago - By: Castle Biosciences, Inc.
Castle Biosciences to Participate in Upcoming Investor Conferences
2 months ago - By: Castle Biosciences, Inc.
Castle Biosciences to Participate in Upcoming Investor Conferences
2 months ago - By: Benzinga
- Mentions:
INSP
MLAB
STAA
VRTX
...
12 Health Care Stocks Moving In Tuesday's Intraday Session
2 months ago - By: Zacks Investment Research
- Mentions:
CLNN
Castle Biosciences, Inc. (CSTL) Q2 Earnings and Revenues Surpass Estimates
2 months ago - By: Castle Biosciences, Inc.
Castle Biosciences Reports Second Quarter 2025 Results
2 months ago - By: Castle Biosciences, Inc.
Castle Biosciences Reports Second Quarter 2025 Results
3 months ago - By: Zacks Investment Research
- Mentions:
TGTX
TG Therapeutics (TGTX) Earnings Expected to Grow: What to Know Ahead of Q2 Release
3 months ago - By: Castle Biosciences, Inc.
Castle Biosciences to Present at the Canaccord Genuity 45th Annual Growth Conference
3 months ago - By: Castle Biosciences, Inc.
Castle Biosciences to Present at the Canaccord Genuity 45th Annual Growth Conference
3 months ago - By: Castle Biosciences, Inc.
Castle Biosciences’ Founder, President and CEO Derek Maetzold Named a Most Admired CEO by the Houston Business Journal
3 months ago - By: Castle Biosciences, Inc.
Castle Biosciences’ Founder, President and CEO Derek Maetzold Named a Most Admired CEO by the Houston Business Journal
3 months ago - By: Castle Biosciences, Inc.
FDA Grants Breakthrough Device Designation to Castle Biosciences’ DecisionDx®-Melanoma Test
3 months ago - By: Castle Biosciences, Inc.
FDA Grants Breakthrough Device Designation to Castle Biosciences’ DecisionDx®-Melanoma Test
3 months ago - By: Castle Biosciences, Inc.
Castle Biosciences Honored with Multiple Top Workplaces Awards Recognizing the Company’s Strong Culture
Please enable JavaScript to continue using this application.